137 related articles for article (PubMed ID: 11112224)
1. Ovarian serous borderline tumors: the citadel defended.
Kurman RJ; Seidman JD
Hum Pathol; 2000 Nov; 31(11):1439-42. PubMed ID: 11112224
[No Abstract] [Full Text] [Related]
2. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.
Bell DA; Longacre TA; Prat J; Kohn EC; Soslow RA; Ellenson LH; Malpica A; Stoler MH; Kurman RJ
Hum Pathol; 2004 Aug; 35(8):934-48. PubMed ID: 15297961
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal recurrences might be less common in advanced stage serous borderline ovarian tumors that were treated by laparotomy.
Vandenput I; Amant F; Vergote I
Gynecol Oncol; 2005 Sep; 98(3):523; author reply 524-5. PubMed ID: 16054202
[No Abstract] [Full Text] [Related]
4. [Ovarian serous tumors of limited malignancy and invasive peritoneal implants. Review of the literature].
Fondrinier E; Seince N; Verriele V; Lorimier G; Gamelin E
Contracept Fertil Sex; 1999 Nov; 27(11):780-4. PubMed ID: 10609410
[TBL] [Abstract][Full Text] [Related]
5. Primary borderline serous neoplasia of the peritoneum.
Gandhi H; Bickerton NJ
J Obstet Gynaecol; 2004 Feb; 24(2):187-8. PubMed ID: 14766470
[No Abstract] [Full Text] [Related]
6. Ovarian serous borderline tumors: the citadel defended.
Kempson RL; Hendrickson MR
Hum Pathol; 2000 May; 31(5):525-6. PubMed ID: 10836290
[No Abstract] [Full Text] [Related]
7. Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor.
Imamura H; Ohishi Y; Aman M; Shida K; Shinozaki T; Yasutake N; Sonoda K; Kato K; Oda Y
Hum Pathol; 2015 Oct; 46(10):1455-63. PubMed ID: 26232113
[TBL] [Abstract][Full Text] [Related]
8. Ovarian micropapillary serous borderline tumors. Clinicopathologic features and outcome of seven surgically staged patients.
Goldstein NS; Ceniza N
Am J Clin Pathol; 2000 Sep; 114(3):380-6. PubMed ID: 10989638
[TBL] [Abstract][Full Text] [Related]
9. Molecular subtypes of serous borderline ovarian tumor show distinct expression patterns of benign tumor and malignant tumor-associated signatures.
Curry EW; Stronach EA; Rama NR; Wang YY; Gabra H; El-Bahrawy MA
Mod Pathol; 2014 Mar; 27(3):433-42. PubMed ID: 23948749
[TBL] [Abstract][Full Text] [Related]
10. Micropapillary serous carcinoma of the ovary has distinct patterns of chromosomal imbalances by comparative genomic hybridization compared with atypical proliferative serous tumors and serous carcinomas.
Staebler A; Heselmeyer-Haddad K; Bell K; Riopel M; Perlman E; Ried T; Kurman RJ
Hum Pathol; 2002 Jan; 33(1):47-59. PubMed ID: 11823973
[TBL] [Abstract][Full Text] [Related]
11. Pathology and classification of ovarian tumors.
Chen VW; Ruiz B; Killeen JL; Coté TR; Wu XC; Correa CN
Cancer; 2003 May; 97(10 Suppl):2631-42. PubMed ID: 12733128
[No Abstract] [Full Text] [Related]
12. [New concepts of pathology in serious borderline tumor in ovarian neoplasm].
Zhou X
Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):182-3. PubMed ID: 10682490
[No Abstract] [Full Text] [Related]
13. Intratumoral Heterogeneity Accounts for Apparent Progression of Noninvasive Serous Tumors to Invasive Low-grade Serous Carcinoma: A Study of 30 Low-grade Serous Tumors of the Ovary in 18 Patients With Peritoneal Carcinomatosis.
Seidman JD; Savage J; Krishnan J; Vang R; Kurman RJ
Int J Gynecol Pathol; 2020 Jan; 39(1):43-54. PubMed ID: 30480646
[TBL] [Abstract][Full Text] [Related]
14. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
[TBL] [Abstract][Full Text] [Related]
15. Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors.
Bijsmans IT; Smits KM; de Graeff P; Wisman GB; van der Zee AG; Slangen BF; de Bruïne AP; van Engeland M; Sieben NL; Van de Vijver KK
Mod Pathol; 2011 Mar; 24(3):463-70. PubMed ID: 21102419
[TBL] [Abstract][Full Text] [Related]
16. Serous tumors of low malignant potential of the ovary. 1. Diagnostic pathology.
Dietel M; Hauptmann S
Virchows Arch; 2000 May; 436(5):403-12. PubMed ID: 10881733
[TBL] [Abstract][Full Text] [Related]
17. The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications.
Meinhold-Heerlein I; Fotopoulou C; Harter P; Kurzeder C; Mustea A; Wimberger P; Hauptmann S; Sehouli J
Arch Gynecol Obstet; 2016 Apr; 293(4):695-700. PubMed ID: 26894303
[TBL] [Abstract][Full Text] [Related]
18. Ruptured benign serous ovarian cystadenoma mimicking ovarian malignancy with peritoneal carcinomatosis.
Boussouar S; Fournier LS; Le-Frere-Belda MA; Kao E; Bats AS; Chamming's F
Diagn Interv Imaging; 2016 Nov; 97(11):1187-1188. PubMed ID: 27421673
[No Abstract] [Full Text] [Related]
19. Cytopathology of serous neoplasia of the ovary and the peritoneum: differential diagnosis from mesothelial proliferations.
Pisharodi LR; Bedrossian CW
Diagn Cytopathol; 1996 Nov; 15(4):292-5. PubMed ID: 8982583
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of peritoneal extensions for the diagnosis and management of serous ovarian borderline tumors].
Andrei S; Stolnicu S; Rădulescu D; Mocan S; Puşcaşu L
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):679-86. PubMed ID: 17571566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]